Taipei, Taiwan

Wan-Yi Hsu

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gnt Biotech & Medicals Corporation. Active years: 2020.


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Wan-Yi Hsu: Innovator in Therapeutic Delivery Systems

Introduction

Wan-Yi Hsu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of innovative delivery systems for therapeutic agents. His work focuses on enhancing the efficacy of drug delivery through advanced materials.

Latest Patents

Wan-Yi Hsu holds a patent for a groundbreaking invention titled "PH-sensitive linkers for delivering a therapeutic agent." This invention provides a pH-sensitive linker that can simultaneously bind metallic nanoparticles and one or more agents of various molecular sizes. The linker is designed to deliver agents into cells involved in disease processes or near cells, allowing for selective targeting and effect on the cells. The target delivery system can be utilized for disease sensing, imaging, drug delivery, and therapy.

Career Highlights

Hsu is currently associated with Gnt Biotech & Medicals Corporation, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential to revolutionize therapeutic delivery methods.

Collaborations

Some of his notable coworkers include Yu-Jung Liao and Wei-Jan Huang, who contribute to the collaborative efforts in advancing their research and development projects.

Conclusion

Wan-Yi Hsu's contributions to the field of therapeutic delivery systems highlight his role as an influential inventor. His innovative approaches have the potential to significantly impact medical treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…